Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
Karyopharm Therapeutics Inc
Autolus Limited
AbbVie
Phoenix Children's Hospital
Orca Biosystems, Inc.
Regeneron Pharmaceuticals
Juno Therapeutics, a Subsidiary of Celgene
Novartis
Novartis
Gilead Sciences
Duke University
AVM Biotechnology Inc
Kura Oncology, Inc.
Kura Oncology, Inc.